In the News
In the News
AOTI wins the Best Newcomer Award at the AIM Awards 2024
London Stock Exchange welcomes AOTI, Inc. celebrating its successful listing on AIM
AOTI announces US FDA 510(k) Clearance of NEXATM NPWT system for use in the home care setting
AOTI, INC. (the “Company” or “Group” or “AOTI”) AOTI announces US FDA 510(k) Clearance of NEXATM NPWT system for use in the home care setting Extension to Indications for Use follows submission of results from a human factors study evaluating the safe and effective...
Treatment Recommendation for Diabetic Foot Ulcers (DFUs) by the Wound Healing Society
AOTI's at-home TWO2® therapy is able to deliver oxygen topically into chronic wounds, including Diabetic Foot Ulcers (DFUs), and to encourage high-quality, durable wound healing OCEANSIDE, Calif., Dec. 4, 2023 /PRNewswire/ -- AOTI Inc., the global leader in...
AOTI to Present Keynote at Advanced Wound Care Summit Europe
Dr. Mike Griffiths to lead discussions on durable wound healing at summit dedicated to advancing commercialization of cutting-edge wound care products OCEANSIDE, Calif., Nov. 27, 2023 /PRNewswire/ -- AOTI Inc., the global leader in multimodality topical wound oxygen...
AOTI Participates in Panel Discussion at Preventing Diabetes-Related Amputations in America
OCEANSIDE, Calif., July 14, 2023 /PRNewswire/ -- AOTI Inc., the global leader in multimodality topical wound oxygen therapy, participated as a founding member of the Amputation Prevention Alliance (APA), in the "Preventing Diabetes-Related Amputations in America: A...
The Most Positive Thing to Happen to Negative Pressure Wound Therapy
OCEANSIDE, Calif., June 7, 2023 /PRNewswire/ -- AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from ongoing WOCNext conference in Las Vegas, Nevada, where their game changing NEXA Negative Pressure Wound Therapy (NPWT)...
Topical Oxygen Therapy Awarded Positive Treatment Recommendation by the International Working Group on the Diabetic Foot in their 2023 Diabetic Foot Ulcer Guidelines
AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from the 9th International Symposium on the Diabetic Foot (ISDF). The IWGDF has recognized the efficacy of topical oxygen therapy in their 2023 Diabetic Foot Ulcer Guidelines, further endorsing AOTI Inc.’s innovative treatment approach.
Topical Oxygen Therapy Awarded “A” Grade Treatment Recommendation by the American Diabetes Association in their 2023 Standards of Care in Diabetes
OCEANSIDE, Calif., Dec. 13, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that the American Diabetes Association has awarded an "A" grade recommendation for utilizing...